Prelude Capital Management’s Adicet Bio ACET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,247
| Closed | -$25.9K | – | 974 |
|
|
2025
Q1 | $25.9K | Buy |
34,247
+5,338
| +18% | +$4.03K | ﹤0.01% | 1032 |
|
|
2024
Q4 | $27.8K | Sell |
28,909
-11,071
| -28% | -$10.7K | ﹤0.01% | 1039 |
|
|
2024
Q3 | $57.6K | Buy |
+39,980
| New | +$57.6K | ﹤0.01% | 1100 |
|
|
2024
Q2 | – | Sell |
-27,810
| Closed | -$65.4K | – | 1092 |
|
|
2024
Q1 | $65.4K | Buy |
+27,810
| New | +$65.4K | ﹤0.01% | 1125 |
|
|
2020
Q3 | – | Sell |
-334
| Closed | -$5K | – | 1316 |
|
|
2020
Q2 | $5K | Buy |
+334
| New | +$5K | ﹤0.01% | 1160 |
|